Replies to post #681414 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Nonsense. Sure he got a few wrong over the years but his track record is good.

>>The worst thing for Adam is that more and more, he has been not just bad and incorrect, but disastrously so, and in time that is going to catch up with him. He keeps apologizing after the fact that oops… he got it wrong.

[Doc logic]

biosectinvestor,

It’s not just that he gets it wrong, it’s the way he gets it wrong and “Adam..antly” insists in spite of the evidence, in spite of the warnings and rebuttals from even the head of a DSMB. The evidence points to collusive efforts being made to target certain companies and that evidence needs to be used to build a coherent case against the abuses that are currently being protected to the point that even those honest and bold enough to rebuke are forced into retractions. These kinds of abuses need to be called out and punished with laws changed to make sure this is not allowed to continue without due recourse for harm being done. Best wishes.

[HyGro]

BPs don't start deals unless they are committed. NWBo could be bought for pocket change. They have no cash to do more trials, barely have cash to pay the rent and have had no interest from BP. Merck has been paying big bucks for their deals and clearly aren't interested in NWBO -- they seen the dubious clinical trial. They have no reason to buy. Personalized oncology treatments have not done well -- just look at CAR-T's.